Sublingual Immunotherapy Tablet Safe in Asthma Patients
(HealthDay News) — For individuals with asthma and allergic rhinitis with/without conjunctivitis (AR/C), treatment with a Timothy grass sublingual immunotherapy tablet (SLIT-tablet) seems safe, according to research published online Dec. 14 in Allergy. Jennifer Maloney, M.D., from Merck & Co. in Whitehouse Station, N.J., and colleagues pooled data from eight randomized, double-blind, placebo-controlled trials of Timothy…